Background. Unplanned rehospitalizations (UR) within 30 days of discharge are common after lung transplantation. It is unknown whether UR represents preventable gaps in care or necessary interventions for complex patients. The objective of this study was to assess the incidence, causes, risk factors, and preventability of UR after initial discharge after lung transplantation.
U nplanned rehospitalizations (UR) within 30 days of discharge are increasingly used as hospital quality of care markers with various penalties and inducements for reaching readmission prevention benchmarks.
1,2 UR are common after solid organ transplantation, particularly for lung transplant recipients where single-center incidence estimates range from 29.8% to 45.4%. [3] [4] [5] [6] Among Medicare recipients undergoing lung transplantation, UR after initial discharge approach 42% depending on center volume. 7 A growing body of retrospective research suggests that these rehospitalizations may be associated with increased mortality, subsequent readmission, and intensive care unit (ICU) utilization. [6] [7] [8] As such, there has been ongoing interest in using UR as a quality marker for lung transplantation programs. 8, 9 It is unclear, however, to what extent UR represents preventable gaps in quality of care or necessary steps to provide timely inpatient interventions to complex patients. 10 Although retrospective data have consistently identified similar reasons for UR within 30 days of initial discharge-infection, arrhythmias, and pleural space/postsurgical complications-there have been no prior studies of the extent to which these rehospitalizations are preventable. Extrapolating from limited data in the kidney transplant literature where preventability estimates are as low as 8.0%, it is possible that lung transplant healthcare professionals, patients, and caregivers can only prevent a small percentage of UR. 11 Previous research in lung transplant recipients has primarily focused on "static" risks for UR such as native lung disease, sex, length of ICU and total hospital stay, and lung allocation score (LAS) rather than potentially modifiable factors. For example, frailty has been associated with UR in kidney transplant recipients and may represent a modifiable risk factor in lung transplant patients. 12 Similarly, the presence of significant patient anxiety has been associated with increased risk for readmission after thoracic surgery and may also be modifiable. 13 Identifying the extent to which URs are preventable and are associated with modifiable risk factors is an essential step in evaluating resource utilization after lung transplant.
The primary aim of this study was to examine prospectively the incidence, causes, direct costs, and preventability of UR within 30 days after discharge after lung transplantation. The secondary aim was to examine whether discharge frailty and anxiety were associated with UR.
MATERIALS AND METHODS

Patient Population and Study Design
This was a prospective cohort study conducted at the Hospital of the University of Pennsylvania (HUP) from March 1, 2016, through February 28, 2017. Lung transplant recipients who survived to initial discharge were eligible to participate. We did not exclude retransplant or multiorgan transplant patients. Study subjects provided informed consent for participation, and the HUP institutional review board approved this study.
Clinical Variable Data Collection
We collected potential explanatory demographic and clinical risk factors for UR based on variables previously identified in lung and other solid organ transplants to be associated with UR. 3, 11, 14 These included age, sex, number of hospitalizations in the year before transplant, concerns regarding social support at the time of listing, or discharge as identified by a moderate or limited Stanford Integrate Psychosocial Assessment for Transplant score in social support domains, native lung disease leading to transplant (categorized as interstitial pulmonary fibrosis [IPF] vs non-IPF), most recent 6-minute walk test distance and percent predicted forced expiratory volume in 1 second (FEV1) before transplantation, and LAS at the time of transplantation. We also collected data on cytomegalovirus mismatch status (donor positive, recipient negative), the presence of any grade 3 primary graft dysfunction at any time point, or acute kidney injury (defined as rise in creatinine >20% from baseline) during the initial transplant hospitalization, the length of ICU and total hospitalization, and the number of standing medications at discharge.
Finally, we recorded discharge destination, categorized as home or an acute rehabilitation facility/long-term acute care hospital (LTACH). We included this variable as a prior study that identified LTACH discharge as the highest risk factor for UR among lung transplant recipients. 3 This study, however, could not evaluate whether this was because patients were seen regularly by LTACH physicians and were readmitted prophylactically for evaluation of a developing problem or because of differences in frailty or illness severity among patients discharged to LTACH versus home. At HUP, all patients not discharged to rehabilitation or an LTACH are seen within 72 hours by a transplant pulmonologist or advanced practitioner. They are all enrolled in an outpatient physical therapy program at HUP 3 times a week and are seen by a transplant pulmonologist or advanced practioner at least weekly during the first month. At these visits, they have routine blood work, pulmonary function tests, and chest imaging.
These included age, sex, number of hospitalizations in the year before transplant, concerns regarding social support at the time of listing or discharge as identified, native lung disease leading to transplant (categorized as IPF vs non-IPF), most recent 6-minute walk test distance and percent predicted FEV1 before transplantation, and LAS at the time of transplantation. We also collected data on cytomegalovirus mismatch status (donor positive, recipient negative), the presence of grade 3 primary graft dysfunction, or acute kidney injury (defined as rise in creatinine >20% from baseline) during the initial transplant hospitalization, the length of ICU and total hospitalization; the number of standing medications at discharge; and discharge destination, categorized as home or an acute rehabilitation facility/LTACH.
Within 48 hours before or after discharge, enrolled patients completed a modified short physical performance battery (SPPB), a 2-component assessment that includes chair stands and balance. 15 The modified SPPB is scored on an 8-point scale that can be treated ordinally (8 points, not frail; 7 points, prefrail; ≤6 points, frail) or continuously. All patients also had a baseline SPPB performed by a trained physical therapist at the time of listing as part of routine pretransplant evaluation. Within 48 hours before discharge, enrolled patients also completed the state-trait anxiety inventory (STAI), a self-reported assessment tool that measures anxiety around a specific situation (state-anxiety) and a subject's disposition toward anxiety (trait-anxiety). 16 The state scale and the trait scale each include 20 items scored on a 4-point Likert response scale with higher scores indicated increased anxiety (Cronbach α, 0.86-0.95). Although there is no specific threshold in the STAI that defines anxious versus nonanxious, the maximum score is 80 and mean scores in the general population run between 31 and 34.
Outcome Definition
The primary study outcome was whether an UR occurred within 30 days after initial discharge. Scheduled or planned admissions that took place within 30 days of a dischargefor example, for a scheduled dialysis catheter change-were not considered UR. Within 72 hours of rehospitalization, the attending or admitting/referring clinician identified the primary reason for readmission and assigned it to 1 of 9 categories derived from a previously published study ( Figure 1 ). 3 For each UR, 1 member of the study staff and the patient's admitting or attending clinician used an ordinal scale (0, not; 1, possibly; 2, definitely preventable) to rate preventability using previously described definitions of preventability. 17 Study staff and admitting/attending clinicians were blind to each other's judgments, and there was good correlation between study staff and admitting/ attending clinician assessment of preventability (Cohen κ = 0.65, P < 0.001). A total sum score of 2 or greater defined a preventable UR. For each preventable UR, the admitting or attending clinician identified the primary reason for why the admission could have been prevented using a previously validated instrument in solid organ transplant (Figure 1) . 11 Costs were broken down into charges, defined as professional charges and hospital charges, and payments defined as professional payments and hospital payments received, as captured from the administration's Horizon Performance Management database.
Statistical Analysis
We used simple descriptive statistics to identify percentages, medians, and quartiles for demographic and clinical variables. We used Fisher exact tests (for categorical variables), Student t tests (for normally distributed continuous variables), and Wilcoxon rank sum tests (for non-normally distributed continuous variables) to compare selected demographic and clinical characteristics for patients with and without an UR. Given the small sample size we only included variables with P values less than 0.15 in a multivariable logistic regression model to identify predictors of any UR. Finally, as a secondary analysis, for patients with at least 90 days of follow-up, we compared whether UR before day 30 were more likely to be categorized as preventable than those between days 30 and 90.
All analyses were performed using Stata (Version 14, Stata Corp, College Station, TX). Study data were collected and managed using Research Electronic Data Capture, an electronic data capture tool hosted at HUP. 18 
RESULTS
Overall Study Cohort
Between March 1, 2016, and February 28, 2017, there were 92 patients eligible for study participation, 90 of whom consented to study enrollment. One patient declined for unspecified reasons and another declined secondary to the perceived complexity of the STAI. Demographic and clinical characteristics of this cohort are listed in Table 1 .
The median number of hospitalizations in the year before transplant was 1 (interquartile range [IQR], 0-2). All enrolled patients had an SPPB of either 7 or 8 at the time of listing, indicating that they were not frail, with a median SPPB of 8. The median time between listing and transplantation was 51 days, and the median LAS at the time of transplant was 39.7. The median length of ICU stay was 6 days, and the median total length of hospitalization was 18 days. The median SPPB at discharge was 4 (IQR, 4-6), and 63 patients (70.0%) had an SPPB less than 6. The median A-state score was 36, and the median A-trait score was 33 (of a total possible 80 points).
Characteristics of Patients With Early UR
Among the 90 patients in the overall cohort, there were 30 (33.3%) UR within 30 days of initial discharge. Comparison of characteristics of patients with and without UR is shown in Table 2 . Concern about social support identified at listing or at initial discharge, the number of hospitalizations in the year before transplantation, length of ICU stay, and total length of hospitalization were not associated with UR. Similarly, neither A-state nor A-trait score at discharge was associated with UR. A diagnosis of pulmonary fibrosis leading to transplant (73.3% vs 50.0%, P = 0.04) and an SPPB < 6 (86.7% vs 61.7%, P = 0.02) was significantly associated with UR.
We then developed a multivariable model of potential risk factors for UR. Because LAS greater than 50 and diagnosis of pulmonary fibrosis were significantly correlated (phi correlation coefficient = 0.25, P = 0.02), our final model included only SPPB less than 6 and LAS greater than 50. On multivariable analysis, SPPB less than 6 remained significantly associated with UR (odds ratio [OR], 3.5; 95% confidence interval [CI], 1.1-11.8, P = 0.04) but LAS greater than 50 was not (OR, 1.7; 95% CI, 0.6-4.5; P = 0.30). Including place of discharge (home vs acute rehabilitation or LTAC facility) in the model did not change the association between SPPB less than 6 and UR (OR, 5.1; 95% CI, 1.4-17.6; P = 0.01).
Epidemiology and Cost of URs
The median time to UR was 9 days (IQR, [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] , and the median length of rehospitalization was 7 days (IQR, 3-13) ( Table 3 ). The single most common reasons for rehospitalization were infection (7 [23.3%]) and atrial tachyarrhythmia (5 [16.7%]). The total charges for all UR were US $7 716 374 and the total payments for all UR were US $1 500 473.
Among the 30 UR, 9 (30.0%) were judged preventable, 78% of which occurred in the first week after discharge (Table 3) . For these UR, the median preventability score was 3, and 6 URs had a score of 3 or higher. The most common reasons cited for preventability were "if communication had been better between inpatient and outpatient/rehabilitation providers" (3 [33.3%]) and "if an alternative medical regimen had been prescribed at discharge" (2 [ 
DISCUSSION
This is the first prospective cohort study in solid organ transplantation of the incidence, causes, costs, and preventability of UR within 30 days of initial discharge. It is also the first study in lung transplantation to use validated frailty and anxiety instruments to assess the impact of these factors on UR. Our primary findings were that a third of lung transplant recipients have an UR within 30 days of discharge and that almost a third of these readmissions are preventable. Among the variables we considered, discharge frailty was significantly associated with UR.
In the last year, there have been 6 studies published on rehospitalization after lung transplantation. [3] [4] [5] [6] 19 Consistent with this growing literature, where the incidence of UR has been reported between 29.8% and 45.4%, 30.0% of patients in our cohort had an UR. Similarly, we found that infection, atrial arrhythmias, and postsurgical complications were the single most common reasons for UR. 6 Readmissions occurred relatively soon after transplant (median 9 days) and were relatively short, with almost half being 5 days or less in duration. The financial burden associated with these readmissions adds increased cost to the health system. STAI scores in our cohort were in keeping with previously reported prelung and postlung transplant values, which have ranged from 36 to 42. [20] [21] [22] Despite evidence in the nontransplant literature that anxiety predicts readmission, we did not find that state or trait anxiety scores were associated with UR. 13, 23 This is consistent with studies Reasons for preventable UR within 30 days of initial discharge (N = 9)
Communication had been better between inpatient and outpatient/inpatient rehabilitation providers 3 (33.3%) An alternative medical regimen had been prescribed at discharge 2 (22.2%) The patient had an outpatient physician/advanced practioner assessment before being admitted 1 (11.1%) The patient had better understood his or her follow-up instructions 1 (11.1%) The patient had a clinical parameter addressed during their index hospitalization 1 (11.1%) Other 1 (11.1%) The patient had adequate support at home 0 (0.0%) The patient had received prescribed medications 0 (0.0%) The patient had been compliant with his or her medication regimen 0 (0.0%) in lung transplant that have found no relationship between STAI score and other posttransplantation outcomes. [20] [21] [22] Since patients with chronic lung diseases have high levels of anxiety pretransplant, it may be that recipients have developed skills or social support networks to cope with these symptoms. 24 We did not have significant numbers of patients with very high levels of anxiety (STAI > 50) and were therefore unable to assess whether severe anxiety was associated with UR.
We were, however, able to consider several other factors not previously examined in the lung transplant rehospitalization literature, including concern about social support at listing or discharge and number of hospitalizations in the year before transplantation. Despite the perception that patients without significant social support or who have a pattern of frequent hospitalizations are more likely to be readmitted, we did not find such an association between these variables and UR. It may be that clinicians identified these patients as being high risk for readmission leading to closer follow-up or monitoring after initial discharge or that our study was underpowered to detect small effects.
Discharge frailty was strongly associated with UR and this study adds to the growing body of literature on the importance of frailty on transplant outcomes. 12, [25] [26] [27] Notably, none of the patients who survived to discharge and were eligible for study enrollment were frail at listing. but a significant number (70.0%) were frail at discharge. Although not a focus of this study, we note that all of patients in our center who were frail at listing died before initial hospital discharge. The rate of discharge frailty in our cohort was consistent with the 82% to 86% frailty rates found among medical ICU survivors. 28 , 29 We also do not know whether frailty developed while on the waitlist, during the index hospitalization, or both; the extent to which frailty could have been prevented; and whether modifying frailty would reduce UR. Importantly, however, frailty was associated with UR independently of discharge to a LTACH or rehabilitation facility suggesting that these rehospitalizations are not just a function of place of discharge. 3, 5 Our center requires recipients to attend outpatient pulmonary rehabilitation at our hospital 3 days a week for up to 12 weeks after initial discharge. This program anecdotally appears to improve frailty trajectories but the actual impact on UR is unknown.
There was a significantly higher rate of preventable UR in our study (30.0%) compared with a prior report of 8.0% in a retrospective chart review study in kidney transplant. 11, 30 Asking clinicians involved in the patient's care to assess preventability near the time of admission is likely a more valid measurement than reconstructing the hospitalization process from the medical record. The 30% incidence in our study was in keeping with estimates in the limited data on preventable readmissions in nontransplant populations such as percutaneous coronary interventions (42.6%) and the general surgical (20.4%) and medical populations (26.9%). 17, 31, 32 Ideally, as many preventable readmissions as possible would be avoided, but it may be that the opportunity costs involved in building frameworks to limit these readmissions could not be justified. Defining an acceptable preventable readmissions rate is, therefore, at least partly a health systems issues. In this context, it would be useful to have multicenter data to define average preventable readmissions rates, whereby unacceptable rates could be defined by relative outlier. Our finding that preventable readmissions are more likely to occur before 30 days than between 30 and 90 days is, however, consistent with health policy strategies that target 30-day readmissions. Given, however, that 78% of preventable UR occurred in the first week after discharge, this may be a more appropriate benchmark if confirmed in a multi-institutional setting. 33 Finally, results also suggest that interventions targeting inpatient and outpatient communication may improve UR rates, as has been noted in the nontransplant literature. 34 Our study has several limitations. First, this was a single institution study and generalizability may be limited because of practice patterns or reasons for readmission specific to our patient population. Second, we were not powered to identify variables with small or moderate effect sizes on UR, and we did not have data on other variables, such as nutritional status, gastroesophageal reflux, duration of air leak, or body fat composition that may be associated with readmission. 5, 19, 35 Finally, we were not able to identify variables specifically associated with preventable readmissions. As we accumulate additional follow-up time, we anticipate being able to assess the relationship between UR and subsequent mortality.
CONCLUSIONS
Although the majority of UR after lung transplant are not preventable, discharge frailty is associated with UR. Further research should identify whether modification of discharge frailty reduces UR.
